Lee Fine Chem: Advancing Innovation and Quality in Intermediates, APIs, and Dosage Forms for Superior Pharmaceutical Solutions.
01 2Lee Fine Chem
02 2Dr. Reddy's Laboratories
03 1Olpha
04 2NanoAlvand
05 1Actavis Inc
06 1Apotex Inc
07 12Astellas Pharma
08 1Eurolab
09 1HAIMEN PHARMA INC
10 2Intas Pharmaceuticals
11 2Pinnacle Life Science
12 3Pluviaendo
13 1Sakar Healthcare
14 2Sandoz B2B
15 1Unichem Laboratories Limited
16 3Vama Lifecare
17 3Zydus Pharmaceuticals
01 2CAP
02 1CAPSULE
03 4CAPSULE;ORAL
04 1Capsule
05 1Capsule, soft
06 1Capsules
07 1Enzalutamide 40Mg 112 Unita' Oral Use
08 2Film Coated Tablet
09 1Filmtabl
10 2Oral Solid Dosage Form
11 1SOFT CAPSULE
12 1Soft Gelatin Capsule
13 1TABLET
14 6TABLET;ORAL
15 11Tablet
16 1Tablet, Soft Gelatine Capsule
17 3capsule
01 3DISCN
02 1Dossier Readiness: Q4 2025
03 2Generic
04 2Lead Market Dossiers- Under Development
05 1Originator
06 3RX
07 28Blank
01 8ENZALUTAMIDE
02 3ENZAVAM
03 4Enzalutamide
04 1Enzutix
05 2Tenzala
06 4XTANDI
07 7Xtandi
08 1Xtandi 40 mg
09 10Blank
01 3Australia
02 1Canada
03 13India
04 2Iran
05 1Italy
06 1Latvia
07 1Norway
08 2South Africa
09 1Sweden
10 1Switzerland
11 3Turkey
12 11USA
Lee Fine Chem: Advancing Innovation and Quality in Intermediates, APIs, and Dosage Forms for Superior Pharmaceutical Solutions.
Regulatory Info :
Registration Country : India
Brand Name : Enzalutamide
Dosage Form : Tablet
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q4 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q4 2025
Registration Country : Latvia
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Tenzala
Dosage Form : Film Coated Tablet
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Lee Fine Chem: Advancing Innovation and Quality in Intermediates, APIs, and Dosage Forms for Superior Pharmaceutical Solutions.
Regulatory Info :
Registration Country : India
Brand Name : Enzalutamide
Dosage Form : Tablet
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Tenzala
Dosage Form : Film Coated Tablet
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2021-05-14
Application Number : 209614
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2022-04-22
Application Number : 209645
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XTANDI
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2012-08-31
Application Number : 203415
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XTANDI
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2020-08-04
Application Number : 213674
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XTANDI
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date : 2020-08-04
Application Number : 213674
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Xtandi
Dosage Form : SOFT CAPSULE
Dosage Strength : 40 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number : 216068
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number : 216068
Regulatory Info :
Registration Country : USA
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2024-09-26
Application Number : 209667
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number : 217322
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number : 217322
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number : 219675
Regulatory Info :
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
